These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9114771)

  • 21. Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol.
    Sekiguchi M; Hoshizaki H; Adachi H; Ohshima S; Taniguchi K; Kurabayashi M
    Circ J; 2004 Jul; 68(7):610-4. PubMed ID: 15226623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures.
    Landzberg BR; Frishman WH; Lerrick K
    Prog Cardiovasc Dis; 1997; 39(4):361-98. PubMed ID: 9050821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
    Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
    Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of cilostazol in percutaneous coronary interventions.
    Rogers KC; Faircloth JM; Finks SW
    Ann Pharmacother; 2012 Jun; 46(6):839-50. PubMed ID: 22669796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Okamoto S; Inden M; Setsuda M; Konishi T; Nakano T
    Am Heart J; 1992 Jun; 123(6):1439-44. PubMed ID: 1595521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study.
    Han Y; Li Y; Wang S; Jing Q; Wang Z; Wang D; Shu Q; Tang X
    Am Heart J; 2009 Apr; 157(4):733-9. PubMed ID: 19332203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cilostazol on intimal proliferation after directional coronary atherectomy.
    Tsuchikane E; Katoh O; Sumitsuji S; Fukuhara A; Funamoto M; Otsuji S; Tateyama H; Awata N; Kobayashi T
    Am Heart J; 1998 Mar; 135(3):495-502. PubMed ID: 9506336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation.
    Inoue T; Uchida T; Sakuma M; Imoto Y; Ozeki Y; Ozaki Y; Hikichi Y; Node K
    J Am Coll Cardiol; 2004 Oct; 44(7):1408-14. PubMed ID: 15464320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.
    Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fabbri M; Fontanelli A; Monici Preti PA; Repetto S; De Servi S
    Circulation; 1994 Dec; 90(6):2710-5. PubMed ID: 7994812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty.
    Schwartz L; Lesperance J; Bourassa MG; Eastwood C; Kazim F; Arafah M; Ganassin L
    Am Heart J; 1990 Feb; 119(2 Pt 1):232-6. PubMed ID: 2405609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty.
    Desmet W; Vrolix M; De Scheerder I; Van Lierde J; Willems JL; Piessens J
    Circulation; 1994 Jan; 89(1):385-92. PubMed ID: 8281674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short-term outcomes of triple antiplatelet therapy after percutaneous coronary intervention].
    Han YL; Su QF; Li Y; Wang SL; Jing QM; Ma YY; Wang ZL; Wang DM; Luan B
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1093-6. PubMed ID: 16796832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A scientific rationale for the CREST trial results: evidence for the mechanism of action of cilostazol in restenosis.
    Morishita R
    Atheroscler Suppl; 2005 Dec; 6(4):41-6. PubMed ID: 16275167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions.
    Iida O; Nanto S; Uematsu M; Morozumi T; Kitakaze M; Nagata S
    J Vasc Surg; 2008 Jul; 48(1):144-9. PubMed ID: 18482817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
    Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
    Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
    Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE
    Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic approaches to restenosis prevention.
    Douglas JS
    Am J Cardiol; 2007 Sep; 100(5A):10K-6K. PubMed ID: 17719348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS.
    Tsuchikane E; Takeda Y; Nasu K; Awata N; Kobayashi T
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):44-51. PubMed ID: 15343566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective randomized antiplatelet trial of cilostazol versus clopidogrel in patients with bare metal stent.
    Chen YD; Lu YL; Jin ZN; Yuan F; Lü SZ
    Chin Med J (Engl); 2006 Mar; 119(5):360-6. PubMed ID: 16542577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose adjunctive cilostazol in patients with complex lesions undergoing percutaneous coronary intervention.
    Zheng XT; Chen KY; Liu T; Xu LX; Che JJ; Rha SW; Li GP
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):29-33. PubMed ID: 26414108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.